Shenzhen Xianle Health Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
- Redemption Price: 101.890 CNY per bond (including interest and tax)
- Date of Satisfaction of Redemption Conditions: March 24, 2026
- Redemption Application Period: March 30, 2026, to April 3, 2026
- Date of Funds Received by Issuer: April 9, 2026
- Date of Fund Transfer for Redemption: April 10, 2026
- Date of Funds Received by Investors: April 13, 2026
- Suspension of Conversion During Redemption Period
- This redemption is not mandatory
- Risk Warning: Choosing redemption is equivalent to selling the "Xianle Convertible Bonds" at 101.890 CNY per bond (including interest and tax). As of now, the closing price of "Xianle Convertible Bonds" is higher than the redemption price, and investors choosing redemption may incur losses; investors are advised to pay attention to risks.
The stock of Shenzhen Xianle Health Technology Co., Ltd. has had a closing price below 70% of the current conversion price of "Xianle Convertible Bonds" (31.86 CNY per share), which is 22.30 CNY per share, for thirty consecutive trading days from February 3, 2026, to March 24, 2026. According to the relevant provisions in the "Prospectus for the Public Offering of Convertible Corporate Bonds by Shenzhen Xianle Health Technology Co., Ltd." (hereinafter referred to as "the Prospectus"), the conditional redemption clause for "Xianle Convertible Bonds" has come into effect. The relevant matters regarding the redemption of "Xianle Convertible Bonds" are announced as follows:
I. Overview of Redemption Situation
According to the Prospectus, the conditional redemption clause is as follows:
- Conditional Redemption Clause If the closing price of the company's stock is below 70% of the current conversion price for any thirty consecutive trading days during the last two interest years of the issued convertible corporate bonds, bondholders have the right to redeem all or part of their convertible corporate bonds at face value plus accrued interest. If there are adjustments to the conversion price due to stock dividends, capital increases, new share issuance (excluding capital increases due to the conversion of these bonds), rights issues, and cash dividends during the aforementioned thirty trading days, the calculations will be based on the closing price and conversion price before and after the adjustment. If the conversion price is adjusted downward, the thirty trading days will be recalculated starting from the first trading day after the adjustment.